Liang-Cheng Chen

Title: Innovations of Liang-Cheng Chen in Nuclear Medicine

Introduction

Liang-Cheng Chen is a notable inventor based in Taoyuan, Taiwan. He has made significant contributions to the field of nuclear medicine, particularly in the development of innovative methods for preparing radiolabeled microspheres. His work is crucial for advancing treatment options for liver tumors.

Latest Patents

Liang-Cheng Chen holds a patent titled "Method for making rhenium-186/188 labeled human serum albumin microspheres and kit for making the same and method for using the kit." This invention relates to a method for preparing Re-labeled human serum albumin (HSA) microspheres using Re(I)-tricarbonyl ion. The radioactive particles produced can be utilized in radioembolization for liver tumors. The method employs Re(I)-tricarbonyl ion (Re(OH)(CO)) as a precursor for directly labeling HSA microspheres at appropriate temperatures.

Career Highlights

Liang-Cheng Chen is affiliated with the Institute of Nuclear Energy Research, where he continues to innovate in the field of nuclear medicine. His work has the potential to improve therapeutic strategies for patients suffering from liver tumors.

Collaborations

Liang-Cheng Chen has collaborated with notable colleagues such as Te-Wei Lee and Chien-Hong Lin. Their combined expertise contributes to the advancement of research in nuclear medicine.

Conclusion

Liang-Cheng Chen's innovative work in developing methods for radiolabeling microspheres represents a significant advancement in nuclear medicine. His contributions are vital for improving treatment options for liver tumors and enhancing patient care.